Cerner Co. (NASDAQ:CERN) – Equities researchers at William Blair dropped their Q1 2018 earnings estimates for Cerner in a note issued to investors on Wednesday. William Blair analyst J. Garro now anticipates that the company will post earnings per share of $0.53 for the quarter, down from their prior estimate of $0.64. William Blair also issued estimates for Cerner’s Q2 2018 earnings at $0.60 EPS, Q3 2018 earnings at $0.63 EPS, Q4 2018 earnings at $0.64 EPS and FY2018 earnings at $2.41 EPS.
CERN has been the topic of a number of other research reports. Zacks Investment Research downgraded Cerner from a “buy” rating to a “hold” rating in a research note on Thursday, January 4th. Cantor Fitzgerald boosted their target price on Cerner to $83.00 and gave the stock an “overweight” rating in a research note on Friday, January 5th. Royal Bank of Canada restated a “buy” rating on shares of Cerner in a research note on Wednesday, October 25th. BidaskClub downgraded Cerner from a “buy” rating to a “hold” rating in a research note on Friday, December 22nd. Finally, Stifel Nicolaus restated a “hold” rating on shares of Cerner in a research note on Wednesday, November 22nd. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have given a buy rating to the company’s stock. Cerner currently has a consensus rating of “Hold” and a consensus target price of $67.05.
Cerner (NASDAQ:CERN) last released its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. Cerner’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.61 EPS.
Several large investors have recently bought and sold shares of the stock. Baird Financial Group Inc. raised its holdings in shares of Cerner by 38.2% in the 4th quarter. Baird Financial Group Inc. now owns 14,715 shares of the company’s stock worth $992,000 after purchasing an additional 4,064 shares during the period. Norinchukin Bank The raised its holdings in shares of Cerner by 7.7% in the 4th quarter. Norinchukin Bank The now owns 25,249 shares of the company’s stock worth $1,702,000 after purchasing an additional 1,804 shares during the period. FDx Advisors Inc. raised its holdings in shares of Cerner by 15.4% in the 4th quarter. FDx Advisors Inc. now owns 22,500 shares of the company’s stock worth $1,516,000 after purchasing an additional 3,005 shares during the period. ARP Americas LP raised its holdings in shares of Cerner by 128.9% in the 4th quarter. ARP Americas LP now owns 6,680 shares of the company’s stock worth $450,000 after purchasing an additional 3,762 shares during the period. Finally, Synovus Financial Corp raised its holdings in shares of Cerner by 2.8% in the 4th quarter. Synovus Financial Corp now owns 46,306 shares of the company’s stock worth $3,114,000 after purchasing an additional 1,241 shares during the period. 81.99% of the stock is currently owned by institutional investors.
In related news, VP Michael R. Battaglioli sold 4,000 shares of Cerner stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $69.89, for a total value of $279,560.00. Following the sale, the vice president now owns 4,000 shares of the company’s stock, valued at approximately $279,560. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Zane M. Burke sold 50,000 shares of Cerner stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $70.00, for a total transaction of $3,500,000.00. The disclosure for this sale can be found here. Insiders sold a total of 784,000 shares of company stock worth $51,926,960 in the last ninety days. 13.11% of the stock is currently owned by insiders.
TRADEMARK VIOLATION WARNING: This piece of content was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/12/cerner-co-cern-forecasted-to-post-q1-2018-earnings-of-0-53-per-share.html.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.